The Centre plans to offload up to 6% in Bank of Maharashtra through an OFS, including a 1% green-shoe option, potentially raising around Rs 2,500 crore and reducing government holding below 75%
Ilumya, a novel biologic treatment that selectively inhibits IL-23, has already established itself as a blockbuster drug internationally, with presence across 35 countries, including the US
The SBI had last year classified the accounts as fraud, alleging misappropriation of funds by entering into transactions that violated the terms of loans extended by it
Fair trade regulator Competition Commission of India (CCI) had already approved this transaction on October 7, 2025
The development features six towers with 23 habitable floors and four basements, and incorporates IGBC-aligned sustainability features
E-commerce company Meesho plans to use Rs 480 crore from the public offer proceeds towards payment of salaries of AI and technology teams, according to draft IPO papers.
Hindustan Unilever has named Vandana Suri to its management committee as executive director for home care, succeeding Srinandan Sundaram, who will become CEO of Unilever International from 1 January
The Delhi High Court issued notices to the CCI and the Centre to respond to Apple's plea challenging rules that allow penalties on a company's global turnover
DBS Bank India acted as the sole advisor and green loan coordinator for this transaction
The company aims to raise RS 300 billion in the current financial year, about half of which has been borrowed already, said chief executive officer and managing director Jairam Sridharan
In the domestic market, the automaker sold 50,340 units, as compared with 48,246 units in November 2024, registering a growth of 4 per cent
The partnership strengthens AU SFB's effort to build a preferred national banking brand with strong consideration across urban, metro, and deeper Bharat markets, the bank said in a statement on Monday
India's largest insurer has, over the years, made investment decisions across companies based on fundamentals and detailed due diligence
To develop premium residential project, eyeing ₹4,150 cr in revenue
The product, a biosimilar to Amgen's popular drug Neulasta, will be manufactured at Lupin's biotech facility in Pune
The new feature strengthens the company's commitment to delivering a transparent, convenient, and customer-first service experience
The company reported a 8 per cent year-on-year growth in total vehicle wholesales, including exports, at 453,273 units in November
The Appointed Date under the scheme is April 1, 2025 and as such, the amalgamation of SMG into and with MSI has been completed, it added
The company has sold properties worth ₹2,600 crore this calendar year in these two projects in Hyderabad
Tata, Mahindra & Mahindra, JSW MG Motor and Hyundai are concerned that a weight-based relief risks hurting India's EV goals